Perampanel in Brain Tumor-Related Epilepsy: A Systematic Review
Brain Sciences · 14.02.2023 · 13 (2) · 326
DOI: 10.3390/brainsci13020326 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Brain Sciences, online erschienen am 14.02.2023. Verfasst von Payam Tabaee Damavandi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Fondazione IRCCS San Gerardo dei Tintori, School of Medicine and Surgery, Milan Center for Neuroscience, University of Milan…. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Brain tumor-related epilepsy (BTRE) is a common comorbidity in patients with brain neoplasms and it may be either the first symptom or develop after the tumor diagnosis. Increasing evidence suggests that brain tumors and BTRE share common pathophysiological mechanisms. Glutamatergic mechanisms can play a central role in promoting both primary brain tumor growth and epileptogenesis. Perampanel (PER), which acts as a selective antagonist of glutamate α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors, may play a role both in the reduction in tumor growth and the control of epileptiform activity. This systematic review aimed to summarize the pre-clinical and clinical evidence about the antitumor properties, antiseizure effects and tolerability of PER in BTRE. Eight pre-clinical and eight clinical studies were identified. The currently available evidence suggests that PER can be an effective and generally well-tolerated therapeutic option in patients with BTRE. In vitro studies demonstrated promising antitumor activity of PER, while no role in slowing tumor progression has been demonstrated in rat models; clinical data on the potential antitumor activity of PER are scarce. Additional studies are needed to explore further the effects of PER on tumor progression and fully characterize its potentialities in patients with BTRE.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Fondazione IRCCS San Gerardo dei Tintori, School of Medicine and Surgery, Milan Center for Neuroscience, University of Milano-Bicocca, 20900 Monza, Italy.
- Department of Neurology, Christian Doppler Klinik, Paracelsus Medical University, 5020 Salzburg, Austria.
- Center for Cognitive Neuroscience, 5020 Salzburg, Austria.
- Public Health, Health Services Research and HTA, University for Health Sciences, Medical Informatics and Technology, 6060 Hall in Tirol, Austria.
- Neurological Clinic, Department of Experimental and Clinical Medicine, Marche Polytechnic University, 60020 Ancona, Italy.
ORCID-Profile: Payam Tabaee Damavandi, Francesco Pasini, Gaia Fanella, Giulia Sofia Cereda, Simona Lattanzi
Zitieren
APA
Tabaee Damavandi, P., Pasini, F., Fanella, G., Cereda, G. S., Mainini, G., DiFrancesco, J. C., Trinka, E., & Lattanzi, S. (2023). Perampanel in Brain Tumor-Related Epilepsy: A Systematic Review. Brain Sciences, 13(2), 326. https://doi.org/10.3390/brainsci13020326
Vancouver
Tabaee Damavandi P, Pasini F, Fanella G, Cereda GS, Mainini G, DiFrancesco JC, et al. Perampanel in Brain Tumor-Related Epilepsy: A Systematic Review. Brain Sciences. 2023;13(2):326. doi:10.3390/brainsci13020326
BibTeX
@article{TabaeeDamavandi2023,
author = {Tabaee Damavandi, Payam and Pasini, Francesco and Fanella, Gaia and Cereda, Giulia Sofia and Mainini, Gabriele and DiFrancesco, Jacopo C and Trinka, Eugen and Lattanzi, Simona},
title = {Perampanel in Brain Tumor-Related Epilepsy: A Systematic Review},
journal = {Brain Sciences},
year = {2023},
volume = {13},
number = {2},
pages = {326},
doi = {10.3390/brainsci13020326}
}
EUVIMED